
Ibclop 75mg Tablet
Marketer
Indiabulls pharmaceutical ltd
Salt Composition
Clopidogrel (75mg)
Overview Ibclop 75mg Tablet
CardioGuard 75mg tablets are antithrombotic agents, preventing the formation of dangerous blood clots within blood vessels. This reduces the risk of stroke and myocardial infarction. A widely prescribed cardioprotective medication, CardioGuard 75mg is indicated for individuals at elevated risk of cardiovascular events. This includes patients with peripheral arterial disease (reduced blood flow due to vascular narrowing), recent stroke or heart attack, cardiac arrhythmias, and post-stent placement. It's also used adjunctively in treating acute myocardial infarction and unstable angina. This medication can be taken with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as cessation increases the risk of stroke or heart attack. The most frequently reported adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Minor wounds may bleed longer than usual. While generally self-limiting, persistent or concerning bleeding requires immediate medical consultation. This medication is contraindicated in individuals with active internal bleeding, such as gastrointestinal ulcers or intracranial hemorrhage. Prior to initiating therapy, disclose any history of bleeding disorders or recent significant trauma or surgical procedures to your physician. Temporary discontinuation may be necessary before elective surgeries or dental procedures.
Uses of Ibclop 75mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ibclop 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg Ibclop tablet whole; do not crush, chew, or divide it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Ibclop 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Ibclop 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ibclop 75mg Tablet whole; do not fracture, pulverize, or chew it. This medication can be administered with or without food, however, consistent timing is recommended.
How Ibclop 75mg Tablet works:
Seven-five milligram Ibclop tablets are antiplatelet agents. Their mechanism involves inhibiting platelet aggregation, thus reducing the incidence of dangerous thrombi. This action diminishes the risk of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Ibclop 75mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Ibclop 75mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the use of Ibclop 75mg tablets while breastfeeding appears to pose minimal risk to the infant. Studies in humans show negligible adverse effects on the nursing child.
DrivingSAFE
Driving ability is typically unaffected by Ibclop 75mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Ibclop 75mg tablets are considered safe to administer without any necessary dosage modifications.
LiverSAFE IF PRESCRIBED
Ibclop 75mg tablets may be administered to patients with hepatic impairment without necessitating a dosage alteration.
What if you forget to take Ibclop 75mg Tablet :
Should you forget to take your Ibclop 75mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ibclop 75mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Amino acid alkyl esters |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
